140 related articles for article (PubMed ID: 36980544)
1. A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment.
Burkart S; Weusthof C; Khorani K; Steen S; Stögbauer F; Unger K; Hess J; Zitzelsberger H; Belka C; Kurth I; Hess J
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980544
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma.
Khorani K; Schwaerzler J; Burkart S; Kurth I; Holzinger D; Flechtenmacher C; Plinkert PK; Zaoui K; Hess J
Mol Cancer Res; 2021 Oct; 19(10):1676-1687. PubMed ID: 34285085
[TBL] [Abstract][Full Text] [Related]
3. High-Resolution Profiling of Head and Neck Squamous Cells Carcinoma Identifies Specific Biomarkers and Expression Subtypes of Clinically Relevant Vulnerabilities.
Zhu Y; Peng B; Luo X; Sun W; Liu D; Li N; Qiu P; Long G
Curr Med Chem; 2023 Nov; ():. PubMed ID: 37936459
[TBL] [Abstract][Full Text] [Related]
4. UCHL1 promotes proliferation and metastasis in head and neck squamous cell carcinoma and could be a potential therapeutic target.
Zhang D; Fu Y; Tian G; Li J; Shang D; Zhou S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):684-697. PubMed ID: 35165060
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
Shimada Y; Kudo Y; Maehara S; Matsubayashi J; Otaki Y; Kajiwara N; Ohira T; Minna JD; Ikeda N
Cancer Sci; 2020 Feb; 111(2):610-620. PubMed ID: 31845438
[TBL] [Abstract][Full Text] [Related]
6. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
Kato N; Yamamoto H; Adachi Y; Ohashi H; Taniguchi H; Suzuki H; Nakazawa M; Kaneto H; Sasaki S; Imai K; Shinomura Y
World J Gastroenterol; 2013 Mar; 19(11):1718-27. PubMed ID: 23555160
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
8. DKK1 affects survival of patients with head and neck squamous cell carcinoma by inducing resistance to radiotherapy and immunotherapy.
Ye X; Liu J; Quan R; Lu Y; Zhang J
Radiother Oncol; 2023 Apr; 181():109485. PubMed ID: 36690301
[TBL] [Abstract][Full Text] [Related]
9. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
10. NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
Pan C; Izreig S; Yarbrough WG; Issaeva N
Cancers Head Neck; 2019; 4():3. PubMed ID: 31321084
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics Analysis of Cancer Cell Lines with High/Low Ferroptosis Scores and Development of a Ferroptosis-Related Model for Multiple Cancer Types.
Shan G; Zhang H; Bi G; Bian Y; Liang J; Valeria B; Zeng D; Yao G; Zhan C; Fan H
Front Cell Dev Biol; 2021; 9():794475. PubMed ID: 34938739
[No Abstract] [Full Text] [Related]
12. An integrative analysis of enhancer of yellow 2 homolog (ENY2) as a molecular biomarker in pan-cancer.
Chen Q; Shi X; Bao Y; Sun G; Wu S; Chen Y
Funct Integr Genomics; 2023 Mar; 23(1):72. PubMed ID: 36862319
[TBL] [Abstract][Full Text] [Related]
13. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
14. Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
Kwan SY; Au-Yeung CL; Yeung TL; Rynne-Vidal A; Wong KK; Risinger JI; Lin HK; Schmandt RE; Yates MS; Mok SC; Lu KH
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31906456
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
Hu Y; Chen J; Liu M; Feng Q; Peng H
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
[TBL] [Abstract][Full Text] [Related]
16. UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.
Yao J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Wang X; Dai J; Xu X
World J Surg Oncol; 2022 May; 20(1):153. PubMed ID: 35546675
[TBL] [Abstract][Full Text] [Related]
17. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
18. Integrative network analysis reveals subtype-specific long non-coding RNA regulatory mechanisms in head and neck squamous cell carcinoma.
Li J; Wu T; Song K; Zhu L; Wang Y; Chen T; Wang X
Comput Struct Biotechnol J; 2023; 21():535-549. PubMed ID: 36659932
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
[TBL] [Abstract][Full Text] [Related]
20. Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan-cancer.
Shen Y; Wei Z; Zhou C; Song J; Wang J; Wang J; Wu L; Fang S; Shen Z
J Clin Lab Anal; 2022 Sep; 36(9):e24600. PubMed ID: 35870182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
